Singapore, May 2, 2008: Mumbai based Aventis Pharma Limited (a Group company of sanofi-aventis) launched a new prefilled disposable insulin pen, SoloSTAR for use with the 24-hour insulin LANTUS. This disposable insulin pen is to be used for the treatment of hyperglycemia in people with type 1 or type 2 diabetes and will be available in India starting April 2008.

 

SoloSTAR is a new, easy-to-use disposable pen for administration of LANTUS. It reduces the injection force by 30% or more in comparison to other disposable pens. This is beneficial to diabetics and in particular for those with lower grip strength and an estimated upto 58% of individuals with limited joint mobility of the hand. SoloSTAR has the highest dose range of any disposable insulin pen with doses up to 80 units adjustable in 1 unit steps. SoloSTAR meets the applicable standards specified by ISO (International Standards Organization) including the standards for dose accuracy.

 

Dr Shailesh Ayyangar, Managing Director , Aventis Pharma said, “LANTUS SoloSTAR is the result of over four years of intensive research and development. This pen has been designed based on inputs from diabetic patients, their nurses and doctors. Thus we are confident that this will cater to the needs of the patients.”

 

“SoloSTAR, an easy-to-use insulin pen brings greater flexibility to patients and an opportunity for earlier initiation of insulin therapy which may contribute to better glycaemic control. This pen is designed in a very convenient manner to enable patients carry it easily, especially while travelling”, said Mr Susheel Umesh, Senior Director - Cardio-Metabolism Business Unit, Aventis Pharma.